We are seeking an experienced, highly quantitative scientist to lead bioanalytical strategy and quality control across a diverse portfolio of peptide, protein, and small molecule therapeutics. This individual will define analytical approaches, oversee external CROs, and ensure that all data generated are accurate, reproducible, and decision-grade.
This role is ideal for someone who combines deep knowledge of bioanalytical methods with a strong QC mindset and the ability to diagnose and resolve complex analytical challenges across multiple assay platforms.
Qualifications
- PhD in Analytical Chemistry, Pharmaceutical Sciences, Biochemistry, or related field
- 8–15+ years of relevant experience in biotech, pharma, or CRO environments
- Demonstrated expertise in bioanalytical method development, validation, and data interpretation within a quality management system (i.e. GLP / GMP)
- Strong understanding of both:
- Instrumental analysis as applied to drug substance drug product characterization
- Experience overseeing and critically evaluating CRO-generated data
- Working knowledge of GLP / GMP analysis and regulatory expectations (e.g., ICH Q2(R2))
- Solid grounding in chemical kinetics and interpretation of concentration–time rate data
- Experience across multiple molecular modalities (polymers, peptides, proteins, and, small molecules)
- Background in analytical development or QC for regulated products
- Experience supporting IND-enabling and early/late stage GMP method validation studies for clinical programs
- Familiarity with complex or long-acting drug delivery systems
Preferred Qualifications
- Own analytical strategy and method validation
- Define fit-for-purpose analytical approaches for drug substance / drug product, and mechanistic studies
- Select appropriate assay platforms (LC, LC-MS, colorimetry, pH, viscosity, osmolarity, endotoxin, bioactivity, and other common USP methods.)
- Validate methods that define our products critical quality attributes.
- Lead CRO oversight
- Design and manage outsourced bioanalytical studies
- Critically review assay development, validation, and sample analysis
- Identify deficiencies in methods, data quality, or interpretation and drive resolution
- Ensure quantitative rigor and data integrity
- Evaluate instrument calibration models, LLOQ, accuracy/precision, and assay robustness
- Detect and troubleshoot issues such as matrix effects, instability, adsorption, and assay interference
- Establish internal standards for data quality across programs
- Apply QC and regulatory principles
- Ensure methods and datasets meet GLP and regulatory expectations (e.g., ICH Q2(R2))
- Contribute to analytical sections of IND-enabling packages and regulatory filings
- Implement quality systems and documentation standards where needed
- Support cross-functional decision making
- Work closely with CMC, pharmacology, and clinical teams to interpret data correctly
- Provide clear recommendations based on quantitative evidence
- Write reports that enable cross-functional understanding of methods and results.
- Operate across modalities
- Apply consistent analytical thinking across polymers, peptides, biologics, and small molecules
- Ensure comparability and continuity of data across platforms and studies
Skills Required
- PhD in Analytical Chemistry, Pharmaceutical Sciences, Biochemistry, or related field
- 8-15+ years of relevant experience in biotech, pharma, or CRO environments
- Demonstrated expertise in bioanalytical method development and validation
- Strong understanding of ligand-binding assays and LC-MS/MS-based quantitation
- Experience overseeing and evaluating CRO-generated data
- Working knowledge of GLP bioanalysis and regulatory expectations
- Grounding in pharmacokinetics and data interpretation
- Experience supporting IND-enabling studies or clinical programs
- Familiarity with complex or long-acting drug delivery systems
What We Do
5AM was founded in 2002 and pursues investments in advanced life science innovations, and seeks to be diversified across the biopharmaceutical therapeutics, and platform technologies. Within each sector, 5AM invests across multiple therapeutic areas and modalities and evaluates opportunities based on innovative platform technologies, corporate spin-offs and products with shorter development cycles. Content 5AM shares on this platform is not, and may not be relied on, in any manner, as legal, tax, investment, accounting or other advice or as an offer to sell or a solicitation of an offer to buy an interest in any private fund, special purpose or other investment vehicle sponsored by 5AM Ventures. Content 5AM shares on this platform is not an investment recommendation. For a full list of all 5AM portfolio companies, please visit: https://5amventures.com/portfolio/








